Evaluation of UGT1A1 and SULT1A1 polymorphisms with lipid levels in women with different hormonal status

References

• Ödmark IS, Bäckström T, Haeger M, Jonsson B, Bixo M. Effects of continuous combined conjugated oestrogen/medroxyprogesterone acetate and 17-estadiol/norethisterone acetate on lipids and lipoproteins. Maturitas 2004;48:137–146.
   PubMedGoogle Scholar
• Deroo BJ, Korach KS. Estrogen receptors and human disease. J Clin Invest 2006;116:561–570.
   PubMed Web of Science ®Google Scholar
• Baudhuin LM, Highsmith WE, Skierka J, Holtegaard L, Moore BE, O'kane DJ. Comparison of three methods for genotyping the UGT1A1 (TA)n repeat polymorphism. Clin Biochem 2007;40:710–717.
   Google Scholar
• Berg JM, Tymoczko JL, Stryer L. Bioquímica. 5th ed. São Paulo: Guanabara Koogan; 2004.
   Google Scholar
• Cribb AE, Knight MJ, Dryer D, Guernsey J, Hender K, Tesch M, Saleh TM. Role of polymorphic human cytochrome P450 enzymes in estrone oxidation. Cancer Epidemiol Biomarkers 2006;15:551–558.
   PubMed Web of Science ®Google Scholar
• Guillemette C, Bélanger A, Lépine J. Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzimes: a overview. Breast Cancer Res 2004;6:246–254.
   PubMed Web of Science ®Google Scholar
• Sparks R, Ulrich CM, Bigler J, Tworoger SS, Yasui Y, Rajan KB, Porter P, Stanczyk FZ, Ballard-Barbash R, Yuan X, et al UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients. Breast Cancer Res 2004;6:488–498.
   PubMed Web of Science ®Google Scholar
• Raftogianis R, Creveling C, Weinshilboum R, Weisz J. Estrogen metabolism by conjugation. J Natl Cancer Inst Monogr 2000;27:113–124.
   PubMedGoogle Scholar
• Ostanek B, Furlan D, Mavec T, Lukac-Bajalo J. UGT1A1(TA)n promoter polymorphism – a new case of a (TA)8 allele in Caucasians. Blood Cells Mol Dis 2007;38:78–82.
   PubMed Web of Science ®Google Scholar
• Raftogianis RB, Wood TC, Weinshilboum RM. Human phenol sulfotransferases SULT1A2 and SULT1A1: genetic polymorphisms, allozyme properties, and human liver genotype–phenotype correlations. Biochem Pharmacol 1999;58:605–616.
   PubMed Web of Science ®Google Scholar
• Coughtrie MW, Gilissen RA, Shek B, Strange RC, Fryer AA, Jones PW, Bamber DE. Phenol sulphotransferase SULT1A1 polymorphism: molecular diagnosis and allele frequencies in Caucasian and African populations. Biochem J 1999;337:45–49.
   PubMed Web of Science ®Google Scholar
• Almeida S, Zandoná MR, Franken N, Osório-Wender MC, Hutz MH. Estrogen receptor 2 and progesterone receptor gene polymorphisms and lipid levels in women with different hormonal status. Pharmacogenomics J 2005;5:30–34.
   PubMed Web of Science ®Google Scholar
• Almeida S, Zandoná MR, Franken N, Callegari-Jacques SM, Osório-Wender MC, Hutz MH. Estrogen-metabolizing gene polymorphisms and lipid levels in women with different hormonal status. Pharmacogenomics J 2005;5:346–351.
   PubMed Web of Science ®Google Scholar
• Almeida S, Fiegenbaum M, Andrade FM, Osório-Wender MC, Hutz MH. ESR1 and APOE gene polymorphisms, serum lipids, and hormonal replacement therapy. Maturitas 2006a;54:119–126.
   PubMed Web of Science ®Google Scholar
• Almeida S, Hutz MH. Estrogen receptor 1 gene polymorphisms and coronary artery disease in the Brazilian population. Braz J Med Biol Res 2006;39:447–454.
   Google Scholar
• American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183–1201.
   PubMed Web of Science ®Google Scholar
• Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.
   PubMed Web of Science ®Google Scholar
• Lahiri DK, Nurnberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991;19:5444.
   PubMed Web of Science ®Google Scholar
• Iolascon A, Faienza MF, Centra M, Storelli S, Zelante L, Savoia A. (TA)8 allele in the UGT1A1 gene promoter of a Caucasian with Gilbert's syndrome. Haematologica 1999;84:106–109.
   PubMed Web of Science ®Google Scholar
• Liang G, Miao X, Zhou Y, Tan W, Lin D. A functional polymorphism in the SULT1A1 gene (G638A) is associated with risk of lung cancer in relation to tobacco smoking. Carcinogenesis 2004;25:773–778.
   Google Scholar
• Abramson JH, Gahlinger PM. Computer programs for epidemiologists: PEPI Version 4.0. Sagelbrush Press: Salt Lake City; 2001.
   Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc Ser B 1995;57:289–300.
   Google Scholar
• Coughtrie MW. Sulfation through the looking glass-recent advances in sulfotransferase research for the curious. Pharmacogenomics J 2002;2:297–308.
   PubMedGoogle Scholar
• Bosma PJ, Van Der Meer IM, Bakker CT, Hofman A, Paul-Abrahamse M, Witteman JC. UGT1A1*28 allele and coronary heart disease: the Rotterdam Study. Clin Chem 2003;49:1180–1181.
   PubMed Web of Science ®Google Scholar
• Gagné JF, Montminy V, Belanger P, Journault K, Gaucher G, Guillemette C. Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38). Mol Pharmacol 2002;62:608–617.
   PubMed Web of Science ®Google Scholar
• Gong QH, Cho JW, Huang T, Potter C, Gholami N, Basu NK, Kubota S, Carvalho S, Pennington MW, Owens IS, et al Thirteen UDPglucoronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 2001;11:357–368.
   PubMedGoogle Scholar
• Lin JP, O'Donnell CJ, Schwaiger JP, Cupples LA, Lingenhel A, Hunt SC, Yang S, Kronenberg F. Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation 2006;114:1476–1481.
   PubMed Web of Science ®Google Scholar
• Raftogianis RB, Wood TC, Otterness DM, Van Loon JA, Weinshilboum RM. Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. Biochem Biophys Res Commun 1997;239:298–304.
   PubMed Web of Science ®Google Scholar
• Ozawa S, Shimizu M, Katoh T, Miyajima A, Ohno Y, Matsumoto Y, Fukuoka M, Tang YM, Lang NP, Kadlubar FF. Sulfating activity and stability of cDNA-expressed allozymes of human phenol sulfotransferase, ST1A3_1 (213Arg) and ST1A3_2 (213His), both of which exist in Japanese as well Caucasians. J. Biochem 1999;126:271–277.
   Google Scholar
• Nowell S, Ambrosone CB, Ozawa S, MacLeod SL, Mrackova G, Williams S, Plaxco J, Kadlubar FF, Lang NP. Relationship of phenol sulfotransferase activity (SULT1A1) genotype to sulfotransferases phenotype in platelet cytosol. Pharmacogenetics 2000;10:789–797.
   PubMedGoogle Scholar
• Nagar S, Walther S, Blanchard RL. Sulfotransferase (SULT) 1A1 polymorphic variants *1, *2, and *3 are associated with altered enzymatic activity, cellular phenotype, and protein degradation. Mol Pharmacol 2006;69:2084–2092.
   PubMed Web of Science ®Google Scholar
• Henderson BE, Paganini-Hill A, Ross PK. Decreased mortality in users of oestrogen replacement therapy. Arch Intern Med 1991;151:17–18.
   Google Scholar
• Zheng W, Xie D, Cerhan JR, Sellers TA, Wen W, Folsom AR. Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure,well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:89–94.
   PubMed Web of Science ®Google Scholar
• Tang D, Rundle A, Mooney L, Cho S, Schnabel F, Estabrook A, Kelly A, Levine R, Hibshoosh H, Perera F. Sulfotransferase 1A1 (SULT1A1) polymorphism, PAH-DNA adduct levels in breast tissue and breast cancer risk in a case–control study. Breast Cancer Res Treat 2003;78:217–222.
   PubMed Web of Science ®Google Scholar
• Saintot M, Malaveille C, Hautefeuille A, Gerber M. Interactions between genetic polymorphism of cytochrome P450-1b1, sulfotransferase 1a1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk. Int J Cancer 2003;107:652–657.
   PubMed Web of Science ®Google Scholar
• Yang G, Gao YT, Cai QY, Shu XO, Cheng JR, Zheng W. Modifying effects of sulfotransferase 1A1 gene polymorphism on the association of breast cancer risk with body mass index or endogenous steroid hormones. Breast Cancer Res Treat 2005;94:63–70.
   PubMed Web of Science ®Google Scholar
• Hirata H, Hinoda Y, Okayama N, Suehiro Y, Kawamoto K, Kikuno N, Rabban JT, Chen LM, Dahiya R. CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility. Cancer 2008;112:1964–1973.
   PubMed Web of Science ®Google Scholar
• Lehtimaki T, Dastidar P, Jokela H, Koivula T, Lehtinen S, Ehnholm C, Punnonen R. Effect of long-term hormone replacement therapy on atherosclerosis progression in postmenopausal women relates to functional apolipoprotein e genotype. J Clin Endocrinol Metab 2002;87:4147–4153.
   PubMed Web of Science ®Google Scholar
• Tolosa M, Peiro S, Real JT, Cano A, Ascaso JF, Carmena R. The influence of apo E phenotypes on the plasma triglycerides response to hormonal replacement therapy during the menopause. Maturitas 2001;40:173–181.
   Google Scholar
• Muhlen D, Barrett-Connor E, Kritz-Silverstein D. Apoliprotein E genotype and response of lipid levels to postmenopausal estrogen use. Atherosclerosis 2002;161:209–214.
   Google Scholar
• Makela R, Karhunen PJ, Kunnas TA, Ilveskoski E, Kajander OA, Mikkelsson J, Perola M, Penttilä A, Lehtimäki T. Myeloperoxidase gene variation as a determinant of atherosclerosis progression in the abdominal and thoracic aorta: an autopsy study. Lab Invest 2003;83:919–925.
   Google Scholar
• Yamakawa-Kobayashi K, Somekawa Y, Fujimura M, Tomura S, Arinami T, Hamaguchi H. Relation of the -514C/T polymorphism in the hepatic lipase gene to serum HDL and LDL cholesterol levels in postmenopausal women under hormone replacement therapy. Atherosclerosis 2002;162:17–21.
   PubMed Web of Science ®Google Scholar
• Fan YM, Dastidar P, Jokela H, Punnonen R, Lehtimäki T. Hepatic lipase C-480T genotype-dependent benefit from long-term hormone replacement therapy for atherosclerosis progression in postmenopausal women. J Clin Endocrinol Metab 2005;90:3786–3792.
   Google Scholar
• Herrington DM, Howard TD, Hawkins GA, Reboussin, DM, Xu J, Zheng SL, Brosnihan KB, Meyers DA, Bleecker ER. Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med 2002;346:967–974.
   PubMed Web of Science ®Google Scholar
• Koivu TA, Fan Y-M, Mattila KM, Dastidar P, Jokela H, Nikkari ST, Kunnas, T, Punnonen R, Lehtimäki T. The effect of hormone replacement therapy on atherosclerotic severity in relation to ESR1 genotype in postmenopausal women. Maturitas 2003;44:29–38.
   PubMed Web of Science ®Google Scholar
• Pernerger TV. What's wrong with Bonferroni adjustments. BMJ 1998;316:1236–1238.
   Google Scholar